Pfizer (NYSE:PFE) and Danish drugmaker Genmab (GMAB) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer therapy, ...
Source LinkPfizer (NYSE:PFE) and Danish drugmaker Genmab (GMAB) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer therapy, ...
Source Link
Comments